ScoreWhy is Dr Agarwals Eye Hospital Ltd ?
1
Healthy long term growth as Net Sales has grown by an annual rate of 26.13% and Operating profit at 38.49%
2
The company has declared Positive results for the last 6 consecutive quarters
- DEBT-EQUITY RATIO(HY) Lowest at 0.94 times
- NET SALES(Q) Highest at Rs 142.97 cr
- PBDIT(Q) Highest at Rs 43.26 cr.
3
With ROCE of 17.3, it has a Fair valuation with a 4.9 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 22.21%, its profits have risen by 31.9% ; the PEG ratio of the company is 1.2
4
Despite the size of the company, domestic mutual funds hold only 0.11% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
5
Consistent Returns over the last 3 years
- Along with generating 22.21% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Dr Agarwal's Eye should be less than 10%
- Overall Portfolio exposure to Hospital should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Hospital)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Dr Agarwal's Eye for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Dr Agarwal's Eye
22.21%
0.76
29.39%
Sensex
-1.65%
-0.12
13.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
26.13%
EBIT Growth (5y)
38.49%
EBIT to Interest (avg)
8.06
Debt to EBITDA (avg)
2.77
Net Debt to Equity (avg)
0.67
Sales to Capital Employed (avg)
0.82
Tax Ratio
24.82%
Dividend Payout Ratio
5.16%
Pledged Shares
7.67%
Institutional Holding
4.29%
ROCE (avg)
14.56%
ROE (avg)
27.84%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
34
Industry P/E
69
Price to Book Value
7.51
EV to EBIT
27.00
EV to EBITDA
18.70
EV to Capital Employed
4.91
EV to Sales
5.70
PEG Ratio
1.21
Dividend Yield
0.12%
ROCE (Latest)
17.28%
ROE (Latest)
22.01%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
DEBT-EQUITY RATIO(HY)
Lowest at 0.94 times
NET SALES(Q)
Highest at Rs 142.97 cr
PBDIT(Q)
Highest at Rs 43.26 cr.
PBT LESS OI(Q)
At Rs 29.00 cr has Grown at 29.52%
PAT(Q)
At Rs 23.38 cr has Grown at 35.5%
EPS(Q)
Highest at Rs 48.41
-3What is not working for the Company
INTEREST(Q)
At Rs 2.77 cr has Grown at 41.33%
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 6.71 cr
Loading Valuation Snapshot...
Here's what is working for Dr Agarwal's Eye
Debt-Equity Ratio - Half Yearly
Lowest at 0.94 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Sales - Quarterly
Highest at Rs 142.97 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 142.97 cr has Grown at 22.28%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 43.26 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 29.00 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 29.00 cr has Grown at 29.52%
Year on Year (YoY)MOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 23.38 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 23.38 cr has Grown at 35.5%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 48.41
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Dr Agarwal's Eye
Interest - Quarterly
At Rs 2.77 cr has Grown at 41.33%
Quarter on Quarter (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 6.71 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
